Fabio Cataldi is listed as a director on 1 SEC Form D filing by 1 issuer in Oct 2026: Thetis Pharmaceuticals LLC (Deep River, CT — pharmaceuticals — 2026; $5.67M reported sold to 52 investors).
What this means One deal on file with the SEC, filed Oct 2026. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside David Cook (1 shared filing), Dennis Willson (1 shared filing), Frank C Sciavolino (1 shared filing), Gary F Mathias (1 shared filing) and Walter Ogier (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Fabio. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 1 public filing for Fabio Cataldi and found 1 difference, 1 worth asking the sponsor about: Form D filed 61 days after the first sale.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.